Related Experiment Video
Updated: Apr 26, 2026

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.7K
Consensus recommendations for using the Multiplate(®) for platelet function monitoring before cardiac surgery
R Kong1, A Trimmings, N Hutchinson
1Royal Sussex County Hospital, Brighton, UK.
International Journal of Laboratory Hematology
|July 25, 2014
Summary
Monitoring platelet function with the Multiplate® analyser helps predict transfusion needs and guides individualized waiting periods after stopping P2Y12 inhibitors before cardiac surgery.
Area of Science:
- Cardiology
- Hematology
- Anesthesiology
Background:
- Patients undergoing urgent cardiac surgery often take antiplatelet drugs, increasing bleeding risk.
- Balancing thrombotic risk and surgical bleeding is a clinical challenge.
- Preoperative platelet function monitoring is crucial for managing antiplatelet therapy.
Purpose of the Study:
- To provide recommendations for using platelet function monitoring in cardiac surgery patients.
- To guide the perioperative management of antiplatelet therapy.
- To optimize patient outcomes by minimizing bleeding and thrombotic complications.
Main Methods:
- Utilizing the Multiplate® (multiple electrode impedance platelet aggregometer) for point-of-care platelet function testing.
- Analyzing real-world, collective clinical experience with the device.
- Developing recommendations for predicting platelet transfusion needs and determining post-cessation waiting periods for P2Y12 inhibitors.
Main Results:
- The Multiplate® analyser can effectively monitor platelet function in patients on antiplatelet therapy.
- Recommendations are provided for individualized perioperative management strategies.
- Evidence-based guidance for predicting transfusion requirements and optimizing waiting times after P2Y12 inhibitor cessation.
Conclusions:
- Platelet function monitoring is essential for safe and effective perioperative management in cardiac surgery.
- The Multiplate® analyser offers a valuable tool for personalized antiplatelet therapy management.
- Recommendations support improved clinical decision-making regarding platelet transfusions and drug cessation timing.
Related Concept Videos
Formation of the Platelet Plug
6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K

